New class of cancer drugs could work in colon cancers with genetic mutation, U-M study finds
Monday, April 25, 2011 - 11:31
in Health & Medicine
ANN ARBOR, Mich. -- A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan ...
